CLINICAL ACTIONS OF FENTANYL AND BUPRENORPHINE - THE SIGNIFICANCE OF RECEPTOR-BINDING
CLINICAL ACTIONS OF FENTANYL AND BUPRENORPHINE - THE SIGNIFICANCE OF RECEPTOR-BINDING
复制标题
DOI:
10.1093/bja/57.2.192
复制
发表时间:
1985-01-01
影响因子:
9.8
通讯作者:
VILLIGER, JW
中科院分区:
文献类型:
--
作者:
BOAS, RA;VILLIGER, JW
Receptor binding assays were undertaken [in rats] to elucidate the opioid binding characteristics of fentanyl and buprenorphine and to investigate some of the differences between them. Buprenorphine showed slow receptor association (30 min), but with high affinity to multiple sites from which dissociation was very slow (T1/2[half-life] = 166 min) and incomplete (50% binding after 1 h). This contrasted with the receptor binding of fentanyl, which achieved rapid equilibrium (within 10 min) and dissociated equally rapidly (T1/2 = 6.8 min) and completely (100% by 1 h). Competitive displacement showed buprenorphine displacement of fentanyl binding was concentration- and time-dependent over ranges encountered in clinical use, but buprenorphine binding was displaced with only very high concentrations of other opioids. These findings offer pharmacodynamic explanations for the differences in fentanyl and buprenorphine analgesic response profiles and suggest how binding interactions might be applied to therapeutic use.